
Over 240 million people worldwide live with chronic hepatitis B

The new three-year agreement builds on an existing two-year relationship

The companies aim to develop next-generation oral medicines for obesity and diabetes

PH has a five‑year survival rate of only around 50% and affects up to 82 million people worldwide

Almost three billion people globally are thought to be either overweight or obese

RSV affects approximately 64 million people around the world each year

Obesity affects approximately 15 million people in the UK

Symptoms of COPD include breathlessness, persistent cough and frequent chest infections

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

Approval supported by positive results from phase 3 trial

The company is planning to submit the candidate for regulatory review by the end of the year

The deal includes a PDE3/4 inhibitor in clinical development for COPD